The clinical retrospective data of patients showed that the strong positive expression of ARNTL in patients was linked to advanced tumor stage, poor tumor survival, lymph node metastasis, increased CA125 concentration, and increased Ki67 positive rates (Table S2). Here, BMAL1 is linked to neoplasm.